4-Bromo-2,3-difluorophenol | CAS:144292-32-0

We serve 4-Bromo-2,3-difluorophenol CAS:144292-32-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromo-2,3-difluorophenol

Chemical Name:4-Bromo-2,3-difluorophenol
CAS.NO:144292-32-0
Synonyms:4-Bromo-2,3-difluorophenol
4-bromo-2,3-difluoro-phenol
2,3-difluoro-4-bromophenol
 
Physical and Chemical Properties:
Density 1.9±0.1 g/cm3
Boiling Point 213.3±35.0 °C at 760 mmHg
Melting Point 49-52°C
Molecular Formula C6H3BrF2O
Molecular Weight 208.988
Flash Point 82.8±25.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.550
 
Specification:
Appearance:Off-white to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Bromo-2,3-difluorophenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-difluoro-4-bromophenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-2,3-difluorophenol Use and application,4-bromo-2,3-difluoro-phenol technical grade,usp/ep/jp grade.


Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.2-Bromo-5H-Benzo[b]carbazole manufacturer Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Decamethylcyclopentasiloxane supplier The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.1-Phenyl-5-pyrazolone-3-carboxylic Acid vendor The first is the API – which is the central ingredient.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.